Home
Inbox
Search
Speaker
Lucy Barker
BSc
Novartis Institutes for Biomedical Research
Bookmark
Session(s)
Fevipiprant, a Potent Selective Prostaglandin D2 Receptor 2 (DP2) Antagonist, Dose-Depende...
Sunday, May 20
11:15 AM - 1:00 PM
Home
Inbox
Search